Cargando…
NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis
Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, an endogenous indoleamine, is considered an important multitasking molecul...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678949/ https://www.ncbi.nlm.nih.gov/pubmed/31311094 http://dx.doi.org/10.3390/ijms20143466 |
_version_ | 1783441223557578752 |
---|---|
author | Bonomini, Francesca Dos Santos, Mariane Veríssimo Veronese, Francisco Rezzani, Rita |
author_facet | Bonomini, Francesca Dos Santos, Mariane Veríssimo Veronese, Francisco Rezzani, Rita |
author_sort | Bonomini, Francesca |
collection | PubMed |
description | Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, an endogenous indoleamine, is considered an important multitasking molecule that has been reported to have anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB)-mediated inflammatory responses in vivo. This molecule has also protective effects against the activation of the inflammasomes and, in particular, the NLRP3 inflammasome. Thus, this work evaluated the effect of melatonin on morphological alteration and NLRP3 inflammasome activation in LN pristane mouse models. To evaluate the melatonin effects in these mice, we studied the renal cytoarchitecture by means of morphological analyses and immunohistochemical expression of specific markers related to oxidative stress, inflammation and inflammasome activation. Our results showed that melatonin attenuates pristane-induced LN through restoring of morphology and attenuation of oxidative stress and inflammation through a pathway that inhibited activation of NLRP3 inflammasome signaling. Our data clearly demonstrate that melatonin has protective activity on lupus nephritis in these mice that is highly associated with its effect on enhancing the Nrf2 antioxidant signaling pathway and decreasing renal NLRP3 inflammasome activation. |
format | Online Article Text |
id | pubmed-6678949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66789492019-08-19 NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis Bonomini, Francesca Dos Santos, Mariane Veríssimo Veronese, Francisco Rezzani, Rita Int J Mol Sci Article Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, an endogenous indoleamine, is considered an important multitasking molecule that has been reported to have anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB)-mediated inflammatory responses in vivo. This molecule has also protective effects against the activation of the inflammasomes and, in particular, the NLRP3 inflammasome. Thus, this work evaluated the effect of melatonin on morphological alteration and NLRP3 inflammasome activation in LN pristane mouse models. To evaluate the melatonin effects in these mice, we studied the renal cytoarchitecture by means of morphological analyses and immunohistochemical expression of specific markers related to oxidative stress, inflammation and inflammasome activation. Our results showed that melatonin attenuates pristane-induced LN through restoring of morphology and attenuation of oxidative stress and inflammation through a pathway that inhibited activation of NLRP3 inflammasome signaling. Our data clearly demonstrate that melatonin has protective activity on lupus nephritis in these mice that is highly associated with its effect on enhancing the Nrf2 antioxidant signaling pathway and decreasing renal NLRP3 inflammasome activation. MDPI 2019-07-15 /pmc/articles/PMC6678949/ /pubmed/31311094 http://dx.doi.org/10.3390/ijms20143466 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bonomini, Francesca Dos Santos, Mariane Veríssimo Veronese, Francisco Rezzani, Rita NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title | NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title_full | NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title_fullStr | NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title_full_unstemmed | NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title_short | NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis |
title_sort | nlrp3 inflammasome modulation by melatonin supplementation in chronic pristane-induced lupus nephritis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678949/ https://www.ncbi.nlm.nih.gov/pubmed/31311094 http://dx.doi.org/10.3390/ijms20143466 |
work_keys_str_mv | AT bonominifrancesca nlrp3inflammasomemodulationbymelatoninsupplementationinchronicpristaneinducedlupusnephritis AT dossantosmariane nlrp3inflammasomemodulationbymelatoninsupplementationinchronicpristaneinducedlupusnephritis AT verissimoveronesefrancisco nlrp3inflammasomemodulationbymelatoninsupplementationinchronicpristaneinducedlupusnephritis AT rezzanirita nlrp3inflammasomemodulationbymelatoninsupplementationinchronicpristaneinducedlupusnephritis |